– CNBC
Pfizer, Biontech Confirm Earlier Reports Cos Submit For U.S. Emergency Use Authorization Of An Additional Booster Dose Of Their COVID-19 Vaccine For Older Adults
Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults
Submission based on real-world safety and efficacy data from Israel
Data showed